Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g

Lupin Pharmaceuticals, Inc. is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for Injection, USP, 500mg, 24 lots of Ceftriaxone for Injection, USP, 1g and 3 lots of Ceftriaxone for Injection, USP 2g, to the hospital/physician level.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news

Related Links:

Source: International Journal of Oral and Maxillofacial Surgery - Category: ENT & OMF Source Type: research
Though the comparison is a bit apples and oranges between now and 1918, the staggering death toll is tragic in any era.Medscape Medical News
Source: Medscape Emergency Medicine Headlines - Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news
A new report claims better federal government coordination is needed, along with an improved public health infrastructure, more tests, and better data on critical supplies.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news
Pediatric Dermatology Part I
Source: Dermatologic Clinics - Category: Dermatology Source Type: research
Esther E. Freeman and Devon E. McMahon
Source: Dermatologic Clinics - Category: Dermatology Source Type: research
BRUCE H. THIERS, MD
Source: Dermatologic Clinics - Category: Dermatology Source Type: research
ELSEVIER
Source: Dermatologic Clinics - Category: Dermatology Source Type: research
DERMATOLOGIC CLINICS
Source: Dermatologic Clinics - Category: Dermatology Authors: Source Type: research
Source: The American Journal of Cardiology - Category: Cardiology Source Type: research
Source: The American Journal of Cardiology - Category: Cardiology Source Type: research
More News: Ceftriaxone | Drugs & Pharmacology | Hospitals | Rocephin